TL
NVO

Tirschwell & Loewy’s Novo Nordisk NVO Stock Holding History

Tirschwell & Loewy’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$19.7M Sell
754,900
-7,700
-1% -$189K 2.7% 18
2018
Q4 		$17.6M Sell
762,600
-52,750
-6% -$1.17M 2.66% 21
2018
Q3 		$19.2M Buy
815,350
+460
+0.1% +$11.2K 2.4% 19
2018
Q2 		$18.8M Buy
814,890
+2,900
+0.4% +$68.9K 2.5% 17
2018
Q1 		$20M Sell
811,990
-970
-0.1% -$25.5K 2.75% 17
2017
Q4 		$21.8M Sell
812,960
-14,970
-2% -$381K 3.08% 14
2017
Q3 		$19.9M Buy
827,930
+8,090
+1% +$183K 3.01% 14
2017
Q2 		$17.6M Buy
819,840
+7,450
+0.9% +$150K 2.76% 16
2017
Q1 		$13.9M Buy
812,390
+11,600
+1% +$202K 2.25% 17
2016
Q4 		$14.4M Buy
800,790
+18,850
+2% +$342K 2.57% 17
2016
Q3 		$16.3M Buy
781,940
+17,190
+2% +$426K 2.7% 15
2016
Q2 		$20.6M Sell
764,750
-16,400
-2% -$450K 3.6% 7
2016
Q1 		$21.2M Sell
781,150
-13,310
-2% -$357K 3.7% 6
2015
Q4 		$23.1M Sell
794,460
-1,800
-0.2% -$49.8K 4.07% 5
2015
Q3 		$21.6M Sell
796,260
-11,450
-1% -$324K 4.07% 6
2015
Q2 		$22.1M Sell
807,710
-7,950
-1% -$223K 3.73% 5
2015
Q1 		$21.8M Sell
815,660
-5,850
-0.7% -$135K 3.63% 7
2014
Q4 		$17.4M Buy
821,510
+7,370
+0.9% +$165K 2.81% 12
2014
Q3 		$19.4M Sell
814,140
-10,300
-1% -$237K 3.24% 8
2014
Q2 		$19M Buy
824,440
+6,060
+0.7% +$134K 3.09% 10
2014
Q1 		$18.7M Buy
818,380
+4,600
+0.6% +$98K 3.21% 9
2013
Q4 		$15M Buy
813,780
+22,200
+3% +$387K 2.61% 16
2013
Q3 		$13.4M Buy
791,580
+65,580
+9% +$1.1M 2.6% 16
2013
Q2 		$11.3M Buy
+726,000
New +$12.1M 2.4% 16

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tirschwell & Loewy's NVO Position: Q1 2019 in Review

Tirschwell & Loewy reduced its Novo Nordisk (NVO) stake by 1% in Q1 2019, selling an estimated $189K and leaving 754,900 shares worth $19.7M. The position accounts for 2.7% of the portfolio, ranked #18.

Tirschwell & Loewy first reported a position in NVO in Q2 2013 and has held it in 24 quarters since. The position peaked at $23.1M in Q4 2015. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

  • Tirschwell & Loewy held 754,900 shares of Novo Nordisk worth $19.7M as of Q1 2019.
  • Tirschwell & Loewy sold 7,700 Novo Nordisk shares in Q1 2019, an estimated $189K.
  • Novo Nordisk made up 2.7% of Tirschwell & Loewy's portfolio in Q1 2019, its #18 holding.
  • Tirschwell & Loewy first reported a position in Novo Nordisk in Q2 2013 and has held it in 24 quarters since.
  • Tirschwell & Loewy's Novo Nordisk position peaked at $23.1M in Q4 2015.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.